Implementing a Digital Alcohol Intervention to Raise Women's Awareness of Alcohol-related Breast Cancer Risk During Routine Screening Visits
Part of paid clinical trials in Miami, Florida.
- Sponsor
- University of Miami
- Study ID
- NCT07799467
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Alcohol Drinking
- Breast Cancer
Eligibility Criteria
- Sex
- FEMALE
- Age
- 40 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Sobriety Digital Intervention — BEHAVIORALParticipants will receive a digital behavioral intervention that includes alcohol use screening, personalized feedback, education on alcohol-related breast cancer risk, brief motivational content, and goal-setting exercises. Participants will retain access to the intervention platform for 4 weeks following the initial intervention.
Study Details
This study is a single-arm feasibility trial evaluating a digital behavioral intervention designed to increase women's awareness of the relationship between alcohol use and breast cancer risk during routine breast cancer screening visits. The study will enroll 36 women aged 40 years or older. Participants will complete baseline measures and receive the Sobriety digital intervention during the clinic visit, followed by 4 weeks of continued access to the platform. Assessments will be completed immediately after the intervention and at 3 months to evaluate feasibility, acceptability, engagement, and changes in alcohol-related knowledge and behavior.
Key Dates
- First listed
- Sep 2, 2026
- Start date
- Oct 15, 2026
- Status verified
- Aug 2026
- Primary completion
- Dec 31, 2026
- Completion
- Mar 31, 2027
Study Design
- Enrollment
- 36 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- PREVENTION
Arms
- Experimental: Single-Cohort Feasibility TrialParticipants will undergo a routine standard-of-care breast cancer screening visit and receive the Sobriety digital behavioral intervention. Participants will maintain access to the digital intervention platform for 4 weeks following the screening visit.
Primary Outcome Measure
Recruitment Rate [ Time Frame: During the recruitment period ]
Central Contacts
- Taghrid Asfar, MD,MSPH305-243-3826
- Maria Fernanda Garcia, BS561-569-7987
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Don Soffer clinical research center | Miami | Florida | 33136 | Taghrid Asfar, MD,MSPH (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Miami, FL
Related Studies
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Women Informed to Screen Depending on Measures of Risk (Wisdom Study)Recruiting · University of California, San Francisco · Birmingham, Alabama
- MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression ProfilesRecruiting · Agendia · Anchorage, Alaska